Arginase‐1+ bone marrow myeloid cells are reduced in myeloproliferative neoplasms and correlate with clinical phenotype, fibrosis, and molecular driver-Reference-Cited by-同舟云学术

Arginase‐1+ bone marrow myeloid cells are reduced in myeloproliferative neoplasms and correlate with clinical phenotype, fibrosis, and molecular driver

Published:2022-12-15 Issue:7 Volume:12 Page:7815-7822
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Bonometti Arturo¹²^ORCID,Borsani Oscar³⁴,Rumi Elisa³⁴,Ferretti Virginia Valeria⁵,Dioli Claudia³,Lucato Elena¹,Paulli Marco¹³,Boveri Emanuela¹

Affiliation:

1. Unit of Anatomic Pathology IRCCS San Matteo Foundation Pavia Italy

2. Pathology Unit Humanitas Clinical and Research Center IRCCS Rozzano Italy

3. Department of Molecular Medicine University of Pavia Pavia Italy

4. Division of Hematology Fondazione IRCCS Policlinico San Matteo Pavia Italy

5. Unit of Clinical Epidemiology and Biostatistics Fondazione IRCCS Policlinico San Matteo Pavia Italy

Funder

Associazione Italiana per la Ricerca sul Cancro

Ministero della Salute

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.5542

Reference35 articles.

1. Myeloproliferative Neoplasms

2. Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both

3. Myeloid-derived suppressor cells coming of age

4. Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DARS expression in BCR/ABL1-negative myeloproliferative neoplasms and its association with the immune microenvironment;Scientific Reports;2024-07-19

2. Circulating Polymorphonuclear Myeloid-Derived Suppressor Cells (PMN-MDSCs) Have a Biological Role in Patients with Primary Myelofibrosis;Cancers;2024-07-16

3. Myelodysplastic/Myeloproliferative Neoplasms with Features Intermediate between Primary Myelofibrosis and Chronic Myelomonocytic Leukemia: Case Series and Review of the Entity;Hemato;2024-07-07

4. TNF-α is a predictive marker in distinguishing myeloproliferative neoplasm and idiopathic erythrocytosis/thrombocytosis: development and validation of a non-invasive diagnostic model;Frontiers in Oncology;2024-03-22

5. Cutaneous involvement in Ph‐negative myeloproliferative neoplasms: from extramedullary hematopoiesis to myeloid metastasis with histiocytic differentiation. A systematic review of the literature;International Journal of Dermatology;2023-08-30